Category: Therapeutic Area
Global Therapeutic Area
-
Acute Coronary Syndrome
... at a CAGR of 10.5% over the analysis period 2024-2030. The U.S. Market is Estimated at US$2.6 Billion While China is Forecast to Grow at 16.2% CAGR The Acute Coronary Syndrome market in the U.S. ... Read More
-
Vertebral Compression Fracture Devices
... 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. Balloon Kyphoplasty, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.2 Billion by the ... Read More
-
Rheumatoid Arthritis Diagnosis Tests
... 2030, growing at a CAGR of 5.8% over the analysis period 2024-2030. Diagnostic Laboratories End-Use, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$478.3 Million by ... Read More
-
Peripheral Arterial Disease (PAD) Therapeutics
... Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Peripheral Stents, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$1.8 Billion ... Read More
-
Cardiology IT Workflow Solutions
... 2030, growing at a CAGR of 8.0% over the analysis period 2024-2030. Cloud, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$1.1 Billion by the end ... Read More
-
Dental Infection Control Products
... 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$1.3 Billion by the end ... Read More
-
Allergy Diagnostics
... CAGR of 10.0% over the analysis period 2024-2030. Assay Kits, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach US$4.5 Billion by the end of the analysis ... Read More
-
Ophthalmology Picture Archiving and Communication Systems
... reach US$211.3 Million by 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Integrated PACS, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach ... Read More
-
Glaucoma Surgery Devices
... at a CAGR of 21.0% over the analysis period 2024-2030. Traditional, one of the segments analyzed in the report, is expected to record a 20.8% CAGR and reach US$3.1 Billion by the end of the ... Read More
-
Pediatric Medical Devices Market Report by Product (IVD Devices, Cardiology Devices, Anesthesia and Respiratory Care Devices, Neonatal ICU Devices, Monitoring Devices, Diagnostic Imaging Devices, Telemedicine, and Others), End User (Hospitals, Diagnostic Laboratories, Pediatric Clinics, and Others), and Region 2025-2033
... 2025-2033. Pediatrics is the branch of medicine that is involved with the health and well-being of children, adolescents, and infants. Pediatric medical devices refer to equipment that is used to treat or diagnose diseases and ... Read More
-
Amyotrophic Lateral Sclerosis Treatment Market Report by ALS Type (Sporadic ALS, Familial ALS), Drug Type (Marketed Drugs, Emerging Drugs), Diagnosis Type (Electromyogram, MRI, Blood and Urine Tests, Spinal Tap, Muscle Biopsy), Treatment (Medication, Stem Cell Therapy, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Region 2025-2033
... during 2025-2033. Amyotrophic Lateral Sclerosis (ALS) Treatment refers to a degenerative disease that affects the nerve cells in the spinal cord and brain, resulting in loss of muscle control. It primarily occurs due to gene ... Read More
-
Clinical Nutrition Market Report by Product (Infant Nutrition, Parental Nutrition, Enteral Nutrition), Route of Administration (Oral, Enteral, Parenteral), Application (Cancer, Malnutrition, Metabolic Disorders, Gastrointestinal Disorders, Neurological Disorders, and Others), End User (Pediatric, Adults, Geriatric), and Region 2025-2033
... are various factors that are driving the market, which include increasing prevalence of chronic diseases and aging population worldwide, rising awareness about the importance of nutrition in healthcare, various technological advancements in personalized nutrition and ... Read More
-
Multi Cancer Early Detection Global Market Report 2025
... early detection market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly ... Read More
-
OTC Dry Eye Drops Global Market Report 2025
... eye drops market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly ... Read More
-
Orthopedic Software
... CAGR of 6.4% over the analysis period 2024-2030. Orthopedic PACS, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$219.4 Million by the end of the analysis ... Read More
-
Lung Cancer Surgery
... at a CAGR of 4.2% over the analysis period 2024-2030. Thoracotomy, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$5.8 Billion by the end of the ... Read More
-
Neuroprosthetics
... 11.9% over the analysis period 2024-2030. Spinal Cord Stimulation, one of the segments analyzed in the report, is expected to record a 13.2% CAGR and reach US$11.7 Billion by the end of the analysis period. ... Read More
-
Orthopedic Surgical Robots
... at a CAGR of 40.2% over the analysis period 2024-2030. Knee Surgery, one of the segments analyzed in the report, is expected to record a 37.6% CAGR and reach US$6.6 Billion by the end of ... Read More
-
Orthopedic Trauma Devices
... at a CAGR of 4.8% over the analysis period 2024-2030. Internal Fixator, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$11.8 Billion by the end of ... Read More
-
Alopecia Drugs
... CAGR of 5.5% over the analysis period 2024-2030. Topical Drugs, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$8.4 Billion by the end of the analysis ... Read More
-
Cancer Supportive Care
... at a CAGR of 2.2% over the analysis period 2024-2030. Opioids, one of the segments analyzed in the report, is expected to record a 2.3% CAGR and reach US$11.1 Billion by the end of the ... Read More
-
Amniocentesis Needles
... CAGR of 2.1% over the analysis period 2024-2030. 150 mm & Above Needles, one of the segments analyzed in the report, is expected to record a 2.4% CAGR and reach US$67.3 Million by the end ... Read More
-
Antipsychotic Drugs
... CAGR of 6.8% over the analysis period 2024-2030. Second Generation Drugs, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$15.7 Billion by the end of the ... Read More
-
Human Papillomavirus (HPV) Testing
... 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Hospitals & Clinics End-Use, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$919.4 Million ... Read More
-
Artificial Joints
... CAGR of 4.4% over the analysis period 2024-2030. Cemented Joints, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$21.2 Billion by the end of the analysis ... Read More
Research Assistance
